iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

110.37 -0.68 (-0.61%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

2 Healthcare Stocks to Keep an Eye On and 1 to Ignore

May 15, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗

May 04, 2025

Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them?

Via Benzinga

Topics Artificial Intelligence

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts ↗

May 02, 2025

iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance.

Via Benzinga

Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled ↗

May 02, 2025

The firm’s new target on iRhythm implies a 19.7% upside to Thursday’s closing price.

Via Stocktwits

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

Breaking Down iRhythm Technologies: 6 Analysts Share Their Views ↗

February 21, 2025

Via Benzinga

This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday ↗

May 02, 2025

Via Benzinga

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday ↗

May 02, 2025

Via Benzinga

Deep Dive Into iRhythm Technologies Stock: Analyst Perspectives (5 Ratings) ↗

May 02, 2025

Via Benzinga

iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic

May 01, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3% year on year to $158.7 million. The company’s...

Via StockStory

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

May 01, 2025

From iRhythm

Via GlobeNewswire

iRhythm Technologies Announces First Quarter 2025 Financial Results

May 01, 2025

From iRhythm

Via GlobeNewswire

iRhythm Earnings: What To Look For From IRTC

April 30, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be reporting results tomorrow afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

April 29, 2025

From iRhythm

Via GlobeNewswire

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

April 28, 2025

From iRhythm

Via GlobeNewswire

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

April 17, 2025

From iRhythm

Via GlobeNewswire

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

April 16, 2025

Report highlights progress against key sustainability initiatives that reflect iRhythm’s commitment to delivering better data, better insights, and better health for all

From iRhythm

Via GlobeNewswire

3 Reasons IRTC is Risky and 1 Stock to Buy Instead

April 10, 2025

iRhythm has been on fire lately. In the past six months alone, the company’s stock price has rocketed 78.8%, reaching $102.62 per share. This was partly thanks to its solid quarterly results, and the...

Via StockStory

Topics Bankruptcy

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

April 08, 2025

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

1 Small-Cap Stock Worth Your Attention and 2 to Question

April 07, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

April 03, 2025

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

Via StockStory

Topics Artificial Intelligence

3 Healthcare Stocks in the Doghouse

March 25, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

March 31, 2025

Two large studies of over one million patients reveal that short-term Holter-duration monitoring frequently misses actionable arrhythmias and that patient-reported symptoms are an unreliable predictor...

From iRhythm

Via GlobeNewswire

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

March 21, 2025

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

March 11, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how ResMed (NYSE:RMD) and the rest...

Via StockStory

Topics Artificial Intelligence

Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't Worried ↗

March 10, 2025

The company is facing a regulatory setback. But one analyst doesn't expect that to impact its upcoming, potential approval.

Via Investor's Business Daily

1 Growth Stock to Target This Week and 2 to Ignore

March 05, 2025

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

Via StockStory

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

February 27, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom...

Via StockStory

Topics Artificial Intelligence

iRhythm (NASDAQ:IRTC) Reports Strong Q4, Stock Soars

February 20, 2025

Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 24% year on year to $164.3 million. The company expects...

Via StockStory

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

February 20, 2025

From iRhythm

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.